SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001439222-19-000027
Filing Date
2019-12-05
Accepted
2019-12-05 16:02:57
Documents
2
Period of Report
2019-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_157557975772173.html 3  
1 FORM 3 wf-form3_157557975772173.xml 3 1720
2 POA DOCUMENT ex-24.htm EX-24 4267
  Complete submission text file 0001439222-19-000027.txt   7431
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Biller Jonathan (Reporting) CIK: 0001744749 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36014 | Film No.: 191270444